companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

UCB PHARMA

SMYRNA-USA

Company Name:
Corporate Name:
UCB PHARMA
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 175 Paterson Ave,SMYRNA,NJ,USA 
ZIP Code:
Postal Code:
30080 
Telephone Number: 973-890-1164 (+1-973--89-0-1164) 
Fax Number: 973-890-5665 (+1-973--89-0-5665) 
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
2833 
USA SIC Description:
Medicinal Chemicals and Botanical Products 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
HIGH STREET COMMUNICATIONS
MAGNA PUBLICATIONS
COUNTRY FOLK
Next company profile:
ALL RISK
GRASSI; REALTORS
GRASSI










Company News:
  • UCB - Inspired by Patients. Driven by Science.
    At UCB, we believe that everyone deserves to live the best life that they can That’s why - as a global biopharmaceutical leader - we’re focused on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
  • UCB in the U. S. | UCB
    UCB is a global biopharma company focused on creating value for people living with severe diseases Learn more about how UCB delivers value for patients through its patient assistance program, treatment tracker and more
  • UCB (company) - Wikipedia
    UCB was founded on 18 January 1928 by Emmanuel Janssen, a Belgian businessman Initially focused on industrial chemicals (it was one of the first companies to distill ammonia from coal), the company also included a small pharmaceutical division based around Meurice Laboratories
  • Medicines | UCB
    UCB's medicines are making a real difference to the lives of people all over the world Some of our products are among the leaders in their field For patients: if you wish to report an adverse event related to one of our products, please contact your healthcare provider
  • About UCB in the United States | UCB
    We incorporate the individual experiences of patients and caregivers into the discovery, development, and delivery of our medicines, leveraging their insights to inform our science and develop innovative and differentiated solutions
  • Our Company | UCB UK
    UCB is a global biopharmaceutical company headquartered in Belgium We employ around 10% of UCB's global workforce - equating more than 1,100 people - in the UK and Ireland in either national, regional or global roles
  • No-Moat UCB Remains Focused On Commercial Launches and Expanding . . .
    UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra Throughout the 1990s and early 2000s, UCB transformed from a hybrid pharma
  • Diseases - UCB
    UCB has a deep heritage in neurology, providing a range of solutions for people living with neurological disorders, including epilepsy and Parkinson’s disease
  • Products | UCB
    Briviact®, Cimzia®, FINTEPLA®, Keppra XR®, Keppra®, Nayzilam®, Neupro® , RYSTIGGO® and ZILBRYSQ® are registered trademarks of the UCB Group of Companies
  • UCB Pharma to initiate phase 3 clinical trial of fenfluramine to treat . . .
    July 31, 2025 UCB Pharma to initiate phase 3 clinical trial of fenfluramine to treat Rett syndrome Industry News UCB




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer